News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. forces completed a third night of strikes, hitting about 140 sites and more than 300 targets this week, increasing regional risk.
  • Japan will press the GPIF to raise allocations to unlisted equities, real estate and other alternatives toward the 5% legal cap from about 1.7%.
  • Yen and Japanese government bonds rose after finance officials urged greater domestic asset exposure.
  • CIBC finds AI-related capital spending will add roughly 0.4 percentage points to U.S. annual inflation in 2026.
  • Geopolitical tensions and persistent inflation are eroding government bonds' protective role, pushing investors toward equities and alternative diversifiers.

Latest Articles

Nuwellis Appoints Mike McCormick as Chief Executive Officer

Nuwellis Appoints Mike McCormick as Chief Executive Officer

Nuwellis, Inc., a US-based medical technology company specializing in cardiorenal care solutions, has appointed Mike McCormick as Chief Executive Officer effective June 30, 2026. McCormick brings over 30 years of leadership experience in medical technology, with proven skills in commercialization and strategic growth. Former CEO John Erb will remai…

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Intelligent Bio Solutions Inc. has initiated an Interference Study to validate the specificity of its Intelligent Fingerprinting Drug Screening System for detecting codeine. This study, conducted alongside other clinical evaluations, aims to fulfill FDA requirements for 510(k) clearance and facilitate planned U.S. market entry by mid-2026. The syst…

NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure

NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure

NewGenIVF Group Limited announced a settlement agreement to repurchase all outstanding convertible notes and warrants held by a significant investor, eliminating potential equity dilution. This move simplifies the capital structure, enhances investor clarity, and better aligns the company's equity value with its net assets. The company plans to con…

Astrotech Board Approves Potential Sale Process of 1st Detect and TRACER 1000, the Only Field-Deployed Mass Spectrometry ETD, as the Company Focuses on Its Initiative in Space

Astrotech Board Approves Potential Sale Process of 1st Detect and TRACER 1000, the Only Field-Deployed Mass Spectrometry ETD, as the Company Focuses on Its Initiative in Space

Astrotech Corporation announced its board's approval to explore the sale of its 1st Detect subsidiary, which develops the TRACER 1000, the only field-deployed mass spectrometry explosives and narcotics trace detection (ETD) platform. This move aims to raise capital for Astrotech's lunar mining initiative. The TRACER 1000 has achieved significant re…

AmpliTech Group Strengthens ORAN 5G Growth Strategy with Addition of Two Senior Business Development Leaders

AmpliTech Group Strengthens ORAN 5G Growth Strategy with Addition of Two Senior Business Development Leaders

AmpliTech Group, a US-based designer and manufacturer of advanced RF and microwave components and 5G infrastructure, has appointed two senior business development representatives with deep telecom experience to support and expand its 5G Open RAN commercial strategy. The additions aim to accelerate the commercialization and deployment of AmpliTech's…

CDT Equity Announces Debt Update and New Loan Facility

CDT Equity Announces Debt Update and New Loan Facility

CDT Equity Inc. has successfully restructured its debt by fully repaying over $6.3 million in legacy financing obligations and entering into a new loan agreement with JJ Astor for up to $1.46 million. This move significantly simplifies the company's capital structure and enhances financial flexibility to support its biopharmaceutical development in…

Unusual Machines Makes $30 Million Strategic Equity Investment in Powerus to Scale U.S. Autonomous Drone Manufacturing Infrastructure

Unusual Machines Makes $30 Million Strategic Equity Investment in Powerus to Scale U.S. Autonomous Drone Manufacturing Infrastructure

Unusual Machines has made a $30 million strategic equity investment in Powerus to expand the manufacturing infrastructure for autonomous drones in the U.S. This investment enhances the existing supply partnership between the two companies and aligns with their shared goal of building a robust American defense-autonomy supply chain. Powerus is also …

Kandal M Venture Secures Structured Growth Capital Facility to Fuel Philippines Manufacturing Operations

Kandal M Venture Secures Structured Growth Capital Facility to Fuel Philippines Manufacturing Operations

Kandal M Venture Limited, a Nasdaq-listed contract manufacturer of affordable luxury leather goods, has closed a $25 million structured growth capital facility through senior unsecured convertible promissory notes. The initial closing provides $1 million to fund equipment and technology upgrades for its Philippine manufacturing plant to scale capac…

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers

FibroBiologics, a clinical-stage biotech company, has commenced dosing patients in its Phase 1/2 clinical trial of CYWC628, an investigational cell-based therapy for diabetic foot ulcers. Parallel advancement in manufacturing supports ongoing clinical activities, demonstrating scalability and consistency in producing CYWC628. The trial will evaluat…

AVAX One Launches AI Inference Pilot, Testing Conversion of Excess Power Capacity to Higher-Value AI Workloads

AVAX One Launches AI Inference Pilot, Testing Conversion of Excess Power Capacity to Higher-Value AI Workloads

AVAX One Technology Ltd. announced the launch of an AI inference pilot at its Redwater facility to convert approximately 100 kilowatts of excess Bitcoin mining capacity into AI workloads. The pilot aims to validate economic assumptions that AI inference can generate significantly higher revenue per kilowatt-hour than Bitcoin mining. The pilot will …

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Quoin Pharmaceuticals announced positive clinical outcomes from its ongoing pediatric compassionate use program of QRX003 for Netherton Syndrome, with four of six children under 10 years old showing significant improvement and no treatment-related adverse events reported. The company plans comprehensive data releases from this program and ongoing P…

XTEND Secures Patent for Operating UAVs Under Degraded Communications and High-Latency Conditions

XTEND Secures Patent for Operating UAVs Under Degraded Communications and High-Latency Conditions

XTEND has been granted a U.S. patent covering technology that allows unmanned aerial vehicles (UAVs) to maintain precise control despite degraded communications and high latency, addressing a critical challenge in autonomous systems. This patent strengthens XTEND’s competitive position in defense and security sectors as it prepares for a business c…

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

Microbot Medical Inc. has entered an agreement with Lovell Government Services, a Service-Disabled Veteran-Owned Small Business, to facilitate access to Microbot's LIBERTY® Endovascular Robotic System for veterans, active military personnel, and Native American communities via federal healthcare systems such as the Veterans Health Administration, M…

D.E. Shaw to Close Lithic Fund to New Capital as Capacity Limits Bite

D.E. Shaw to Close Lithic Fund to New Capital as Capacity Limits Bite

D.E. Shaw & Co. is preparing to close its Lithic fund to new money as early as next month, according to reporting that cites people familiar with the matter. The fund oversees more than $5 billion. The decision comes as part of a broader wave of hedge funds restricting inflows even as investor interest in the sector increases. D.E. Shaw manages in …

InterDigital Director Samir Armaly Sells Shares Under Pre-Arranged Plan

InterDigital Director Samir Armaly Sells Shares Under Pre-Arranged Plan

InterDigital, Inc. (NASDAQ: IDCC) director Samir Armaly executed a sale of 470 common stock shares on June 12, 2026, generating $130,020 at $276.64 per share. The transaction, governed by a Rule 10b5-1 trading plan adopted on August 8, 2025, was structured to cover estimated tax liabilities from restricted stock unit vesting. Following the sale, Ar…

InterDigital Director Derek Aberle Executes Pre-Arranged Stock Sale

InterDigital Director Derek Aberle Executes Pre-Arranged Stock Sale

InterDigital Inc. (NASDAQ: IDCC) director Derek Aberle executed a transaction involving 522 shares of the company's common stock on June 12, 2026. The sale was conducted at a price of $276.64 per share, resulting in a total transaction value of $144,406. This activity was carried out under a Rule 10b5-1 trading plan that Aberle established on Novem…

Yum Brands to Divest Pizza Hut in $2.7 Billion Deal

Yum Brands to Divest Pizza Hut in $2.7 Billion Deal

Yum Brands announced it will sell Pizza Hut for a combined $2.7 billion, splitting the chain between Yum China, which will pay $1.2 billion for the Mainland China operations, and private equity firm LongRange Capital, which will pay $1.5 billion for the rest of the business. The move follows exclusive talks with LongRange after Yum reviewed strateg…

Clover Health CEO Jamie Reynoso Executes RSU-Related Stock Sale Amid Regulatory and Financial Developments

Clover Health CEO Jamie Reynoso Executes RSU-Related Stock Sale Amid Regulatory and Financial Developments

Jamie L. Reynoso, Chief Executive Officer of Clover Health Investments Corp. (NASDAQ: CLOV), completed the sale of 6,350 shares of the company's Class A Common Stock on June 15, 2026. The transaction, valued at $29,273, was executed to fulfill mandatory tax withholding requirements tied to the vesting of restricted stock units (RSUs). This sale fol…

California Resources Corporation Announces Private Offering of $550 Million of Senior Unsecured Notes

California Resources Corporation Announces Private Offering of $550 Million of Senior Unsecured Notes

California Resources Corporation announced a $550 million private offering of senior unsecured notes due 2035. The company plans to use the proceeds along with other funds to redeem $550 million of its 8.250% senior notes due 2029 at a premium. The notes will be guaranteed by CRC's subsidiaries and offered only to qualified institutional buyers and…